Puma Biotechnology (PBYI) Income towards Parent Company: 2017-2025
Historic Income towards Parent Company for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to $8.8 million.
- Puma Biotechnology's Income towards Parent Company fell 56.47% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 28.66%. This contributed to the annual value of $23.2 million for FY2024, which is 7.47% up from last year.
- According to the latest figures from Q3 2025, Puma Biotechnology's Income towards Parent Company is $8.8 million, which was up 51.05% from $5.9 million recorded in Q2 2025.
- Over the past 5 years, Puma Biotechnology's Income towards Parent Company peaked at $20.3 million during Q3 2024, and registered a low of -$44.7 million during Q3 2021.
- Moreover, its 3-year median value for Income towards Parent Company was $5.8 million (2023), whereas its average is $5.7 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 1,710.00% in 2023, then tumbled by 443.68% in 2024.
- Over the past 5 years, Puma Biotechnology's Income towards Parent Company (Quarterly) stood at $4.2 million in 2021, then crashed by 232.72% to -$5.6 million in 2022, then surged by 318.84% to $12.3 million in 2023, then dropped by 0.31% to $12.2 million in 2024, then plummeted by 56.47% to $8.8 million in 2025.
- Its Income towards Parent Company stands at $8.8 million for Q3 2025, versus $5.9 million for Q2 2025 and $3.0 million for Q1 2025.